HK1125289A1 - Sustained-release preparation - Google Patents

Sustained-release preparation

Info

Publication number
HK1125289A1
HK1125289A1 HK09103098.6A HK09103098A HK1125289A1 HK 1125289 A1 HK1125289 A1 HK 1125289A1 HK 09103098 A HK09103098 A HK 09103098A HK 1125289 A1 HK1125289 A1 HK 1125289A1
Authority
HK
Hong Kong
Prior art keywords
sustained
release preparation
release
preparation
Prior art date
Application number
HK09103098.6A
Other languages
English (en)
Inventor
Hirohiko Sato
Tatsuro Yokoyama
Shota Kanezaki
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of HK1125289A1 publication Critical patent/HK1125289A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK09103098.6A 2005-08-23 2009-04-01 Sustained-release preparation HK1125289A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005241776 2005-08-23
PCT/JP2006/316181 WO2007023729A1 (fr) 2005-08-23 2006-08-17 Préparation à libération retardée

Publications (1)

Publication Number Publication Date
HK1125289A1 true HK1125289A1 (en) 2009-08-07

Family

ID=37771477

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09103098.6A HK1125289A1 (en) 2005-08-23 2009-04-01 Sustained-release preparation

Country Status (12)

Country Link
US (1) US20090117190A1 (fr)
EP (1) EP1927358A4 (fr)
JP (1) JPWO2007023729A1 (fr)
KR (1) KR20080055797A (fr)
CN (1) CN101277699B (fr)
AU (1) AU2006282506A1 (fr)
BR (1) BRPI0614949A2 (fr)
CA (1) CA2620259A1 (fr)
HK (1) HK1125289A1 (fr)
IL (1) IL189681A0 (fr)
TW (1) TW200800207A (fr)
WO (1) WO2007023729A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011099573A1 (fr) 2010-02-12 2011-08-18 大正製薬株式会社 Préparation à libération prolongée
US9446000B2 (en) * 2011-09-08 2016-09-20 Masdar Institute Of Science And Technology Cellulosic gel material as a pharmaceutical excipient
CN110251475B (zh) * 2019-07-25 2021-07-16 沈阳信康药物研究有限公司 一种帕利哌酮片剂及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
JPH0759521B2 (ja) * 1985-09-30 1995-06-28 藤沢薬品工業株式会社 ゲル層形成型徐放性製剤
US4798725A (en) * 1986-06-16 1989-01-17 Norwich Eaton Pharmaceuticals, Inc. Sustained release capsule
HU226456B1 (en) * 1992-09-18 2008-12-29 Astellas Pharma Inc Sustained-release hydrogel preparation
JP3598049B2 (ja) * 1992-09-18 2004-12-08 山之内製薬株式会社 ハイドロゲル徐放性製剤
JP4292588B2 (ja) * 1997-01-31 2009-07-08 日産化学工業株式会社 ピリダジノン化合物類の経口製剤
TW482675B (en) * 1997-01-31 2002-04-11 Green Cross Corp Compositions for oral administration containing pyridazinone compounds technical field of the invention
US6403597B1 (en) * 1997-10-28 2002-06-11 Vivus, Inc. Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
AU735147B2 (en) * 1997-12-26 2001-07-05 Toray Industries, Inc. Sustained-release pharmaceutical composition
US6387383B1 (en) * 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
JP2002068964A (ja) * 2000-08-24 2002-03-08 Nichiko Pharmaceutical Co Ltd 経口用徐放錠

Also Published As

Publication number Publication date
IL189681A0 (en) 2008-06-05
TW200800207A (en) 2008-01-01
BRPI0614949A2 (pt) 2011-04-26
WO2007023729A1 (fr) 2007-03-01
JPWO2007023729A1 (ja) 2009-02-26
CA2620259A1 (fr) 2007-03-01
AU2006282506A1 (en) 2007-03-01
EP1927358A4 (fr) 2010-10-13
KR20080055797A (ko) 2008-06-19
CN101277699B (zh) 2011-01-12
CN101277699A (zh) 2008-10-01
EP1927358A1 (fr) 2008-06-04
US20090117190A1 (en) 2009-05-07

Similar Documents

Publication Publication Date Title
AP2108A (en) Novel biphenylsulfonamides
ZA200805147B (en) Solid preparation
EP1897558A4 (fr) Preparation solide
IL187919A0 (en) 4c
EP1825866A4 (fr) Preparation solide
DE602006003064D1 (en) Tripeptid- und tetrapeptid-thioether
DE602006009492D1 (en) Fluidmaschinen
DE502005007477D1 (en) Delta-sigma-modulator
EP1712218A4 (fr) Preparation de teinture capillaire
IL190616A0 (en) Novel selection system
ZA200801986B (en) Standard
HK1125289A1 (en) Sustained-release preparation
DE502006002219D1 (en) Rotationspumpe
DE502006004337D1 (en) Strangführungsrolle
DE502006007734D1 (en) Thiazolcarbonsäureanilide
EP1864664A4 (fr) Preparation pharmaceutique
AU3237P (en) Balcabpink Calibrachoa
PL367010A1 (en) Anti-recession preparation
AU3393P (en) Breakwell xTriticosecale
AU3401P (en) Archise Arctotis fastuosa
AU3621P (en) Scacover Scaevola aemula
AU3685P (en) DOW10 Tristaniopsis laurina
AU4036P (en) Dottie Calathea roseo-picta
AU3292P (en) DP303 Dianella prunina
GB0415721D0 (en) Novel preparation

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150817